vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and CPI Card Group Inc. (PMTS). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $153.1M, roughly 1.1× CPI Card Group Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 22.3%). Over the past eight quarters, CPI Card Group Inc.'s revenue compounded faster (16.9% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.
ESPR vs PMTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $153.1M |
| Net Profit | — | $7.3M |
| Gross Margin | — | 31.5% |
| Operating Margin | 50.6% | 12.0% |
| Net Margin | — | 4.8% |
| Revenue YoY | 143.7% | 22.3% |
| Net Profit YoY | — | 8.5% |
| EPS (diluted) | $0.32 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $153.1M | ||
| Q3 25 | $87.3M | $138.0M | ||
| Q2 25 | $82.4M | $129.8M | ||
| Q1 25 | $65.0M | $122.8M | ||
| Q4 24 | $69.1M | $125.1M | ||
| Q3 24 | $51.6M | $124.8M | ||
| Q2 24 | $73.8M | $118.8M | ||
| Q1 24 | $137.7M | $111.9M |
| Q4 25 | — | $7.3M | ||
| Q3 25 | $-31.3M | $2.3M | ||
| Q2 25 | $-12.7M | $518.0K | ||
| Q1 25 | $-40.5M | $4.8M | ||
| Q4 24 | — | $6.8M | ||
| Q3 24 | $-29.5M | $1.3M | ||
| Q2 24 | $-61.9M | $6.0M | ||
| Q1 24 | $61.0M | $5.5M |
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 29.7% | ||
| Q2 25 | — | 30.9% | ||
| Q1 25 | — | 33.2% | ||
| Q4 24 | — | 34.1% | ||
| Q3 24 | — | 35.8% | ||
| Q2 24 | — | 35.7% | ||
| Q1 24 | — | 37.1% |
| Q4 25 | 50.6% | 12.0% | ||
| Q3 25 | -11.4% | 9.4% | ||
| Q2 25 | 8.6% | 7.3% | ||
| Q1 25 | -34.0% | 11.5% | ||
| Q4 24 | -6.4% | 12.7% | ||
| Q3 24 | -31.0% | 14.3% | ||
| Q2 24 | 3.5% | 12.5% | ||
| Q1 24 | 52.5% | 12.6% |
| Q4 25 | — | 4.8% | ||
| Q3 25 | -35.9% | 1.7% | ||
| Q2 25 | -15.4% | 0.4% | ||
| Q1 25 | -62.2% | 3.9% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | -57.2% | 1.0% | ||
| Q2 24 | -83.9% | 5.1% | ||
| Q1 24 | 44.3% | 4.9% |
| Q4 25 | $0.32 | $0.62 | ||
| Q3 25 | $-0.16 | $0.19 | ||
| Q2 25 | $-0.06 | $0.04 | ||
| Q1 25 | $-0.21 | $0.40 | ||
| Q4 24 | $-0.14 | $0.56 | ||
| Q3 24 | $-0.15 | $0.11 | ||
| Q2 24 | $-0.33 | $0.51 | ||
| Q1 24 | $0.34 | $0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $21.7M |
| Total DebtLower is stronger | — | $286.7M |
| Stockholders' EquityBook value | $-302.0M | $-17.3M |
| Total Assets | $465.9M | $403.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $21.7M | ||
| Q3 25 | $92.4M | $16.0M | ||
| Q2 25 | $86.1M | $17.1M | ||
| Q1 25 | $114.6M | $31.5M | ||
| Q4 24 | $144.8M | $33.5M | ||
| Q3 24 | $144.7M | $14.7M | ||
| Q2 24 | $189.3M | $7.5M | ||
| Q1 24 | $226.6M | $17.1M |
| Q4 25 | — | $286.7M | ||
| Q3 25 | — | $308.4M | ||
| Q2 25 | — | $310.9M | ||
| Q1 25 | — | $280.7M | ||
| Q4 24 | — | $280.4M | ||
| Q3 24 | — | $280.2M | ||
| Q2 24 | — | $269.7M | ||
| Q1 24 | — | $265.3M |
| Q4 25 | $-302.0M | $-17.3M | ||
| Q3 25 | $-451.4M | $-25.7M | ||
| Q2 25 | $-433.5M | $-29.0M | ||
| Q1 25 | $-426.2M | $-29.7M | ||
| Q4 24 | $-388.7M | $-35.6M | ||
| Q3 24 | $-370.2M | $-42.8M | ||
| Q2 24 | $-344.2M | $-44.6M | ||
| Q1 24 | $-294.3M | $-48.5M |
| Q4 25 | $465.9M | $403.2M | ||
| Q3 25 | $364.0M | $407.1M | ||
| Q2 25 | $347.1M | $399.8M | ||
| Q1 25 | $324.0M | $351.9M | ||
| Q4 24 | $343.8M | $349.7M | ||
| Q3 24 | $314.1M | $342.3M | ||
| Q2 24 | $352.3M | $321.4M | ||
| Q1 24 | $373.1M | $319.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $39.6M |
| Free Cash FlowOCF − Capex | — | $35.2M |
| FCF MarginFCF / Revenue | — | 23.0% |
| Capex IntensityCapex / Revenue | 0.0% | 2.9% |
| Cash ConversionOCF / Net Profit | — | 5.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $39.6M | ||
| Q3 25 | $-4.3M | $10.0M | ||
| Q2 25 | $-31.4M | $4.3M | ||
| Q1 25 | $-22.6M | $5.6M | ||
| Q4 24 | $-35.0M | $26.7M | ||
| Q3 24 | $-35.3M | $12.5M | ||
| Q2 24 | $-7.2M | $-4.8M | ||
| Q1 24 | $53.8M | $8.9M |
| Q4 25 | — | $35.2M | ||
| Q3 25 | — | $5.3M | ||
| Q2 25 | — | $533.0K | ||
| Q1 25 | — | $292.0K | ||
| Q4 24 | — | $21.6M | ||
| Q3 24 | $-35.5M | $11.1M | ||
| Q2 24 | $-7.3M | $-6.0M | ||
| Q1 24 | $53.8M | $7.4M |
| Q4 25 | — | 23.0% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 17.3% | ||
| Q3 24 | -68.7% | 8.9% | ||
| Q2 24 | -9.9% | -5.0% | ||
| Q1 24 | 39.0% | 6.6% |
| Q4 25 | 0.0% | 2.9% | ||
| Q3 25 | 0.0% | 3.4% | ||
| Q2 25 | 0.0% | 2.9% | ||
| Q1 25 | 0.0% | 4.3% | ||
| Q4 24 | 0.0% | 4.0% | ||
| Q3 24 | 0.3% | 1.2% | ||
| Q2 24 | 0.1% | 1.0% | ||
| Q1 24 | 0.1% | 1.3% |
| Q4 25 | — | 5.39× | ||
| Q3 25 | — | 4.32× | ||
| Q2 25 | — | 8.39× | ||
| Q1 25 | — | 1.17× | ||
| Q4 24 | — | 3.94× | ||
| Q3 24 | — | 9.70× | ||
| Q2 24 | — | -0.79× | ||
| Q1 24 | 0.88× | 1.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PMTS
| US Debit And Credit | $128.9M | 84% |
| US Prepaid Debit | $24.4M | 16% |
